These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 17504928)

  • 21. Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth.
    Edwards LA; Thiessen B; Dragowska WH; Daynard T; Bally MB; Dedhar S
    Oncogene; 2005 May; 24(22):3596-605. PubMed ID: 15782140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the anti-apoptotic Akt/protein kinase B pathway in human malignant gliomas in vivo.
    Schlegel J; Piontek G; Mennel HD
    Anticancer Res; 2002; 22(5):2837-40. PubMed ID: 12530006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTEN signaling pathways in glioblastoma.
    Koul D
    Cancer Biol Ther; 2008 Sep; 7(9):1321-5. PubMed ID: 18836294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glioma biology and molecular markers.
    Cohen AL; Colman H
    Cancer Treat Res; 2015; 163():15-30. PubMed ID: 25468223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of EGFR and PTEN numerical aberrations in the evaluation of diffusely infiltrating astrocytomas. Laboratory investigation.
    Mott RT; Turner KC; Bigner DD; McLendon RE
    J Neurosurg; 2008 Feb; 108(2):330-5. PubMed ID: 18240930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Histological and molecular classification of gliomas].
    Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
    Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin.
    Lai A; Kharbanda S; Pope WB; Tran A; Solis OE; Peale F; Forrest WF; Pujara K; Carrillo JA; Pandita A; Ellingson BM; Bowers CW; Soriano RH; Schmidt NO; Mohan S; Yong WH; Seshagiri S; Modrusan Z; Jiang Z; Aldape KD; Mischel PS; Liau LM; Escovedo CJ; Chen W; Nghiemphu PL; James CD; Prados MD; Westphal M; Lamszus K; Cloughesy T; Phillips HS
    J Clin Oncol; 2011 Dec; 29(34):4482-90. PubMed ID: 22025148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
    Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
    Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic pathways to primary and secondary glioblastoma.
    Ohgaki H; Kleihues P
    Am J Pathol; 2007 May; 170(5):1445-53. PubMed ID: 17456751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.
    Choe G; Park JK; Jouben-Steele L; Kremen TJ; Liau LM; Vinters HV; Cloughesy TF; Mischel PS
    Clin Cancer Res; 2002 Sep; 8(9):2894-901. PubMed ID: 12231534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival.
    McBride SM; Perez DA; Polley MY; Vandenberg SR; Smith JS; Zheng S; Lamborn KR; Wiencke JK; Chang SM; Prados MD; Berger MS; Stokoe D; Haas-Kogan DA
    J Neurooncol; 2010 Mar; 97(1):33-40. PubMed ID: 19705067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas.
    Grasbon-Frodl EM; Kreth FW; Ruiter M; Schnell O; Bise K; Felsberg J; Reifenberger G; Tonn JC; Kretzschmar HA
    Int J Cancer; 2007 Dec; 121(11):2458-64. PubMed ID: 17691113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PTEN, DMBT1, and p16 alterations in diffusely infiltrating astrocytomas.
    Fan X; Muñoz J; Sanko SG; Castresana JS
    Int J Oncol; 2002 Sep; 21(3):667-74. PubMed ID: 12168116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of PTEN binding adapter protein NHERF1 from plasma membrane in glioblastoma contributes to PTEN inactivation.
    Molina JR; Morales FC; Hayashi Y; Aldape KD; Georgescu MM
    Cancer Res; 2010 Sep; 70(17):6697-703. PubMed ID: 20736378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression.
    Zheng S; Houseman EA; Morrison Z; Wrensch MR; Patoka JS; Ramos C; Haas-Kogan DA; McBride S; Marsit CJ; Christensen BC; Nelson HH; Stokoe D; Wiemels JL; Chang SM; Prados MD; Tihan T; Vandenberg SR; Kelsey KT; Berger MS; Wiencke JK
    Neuro Oncol; 2011 Mar; 13(3):280-9. PubMed ID: 21339190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular pathways in gliomagenesis and their relevance to neuropathologic diagnosis.
    Appin CL; Brat DJ
    Adv Anat Pathol; 2015 Jan; 22(1):50-8. PubMed ID: 25461780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of PTEN promoter methylation in cerebral cavernous malformations.
    Zhu Y; Wloch A; Wu Q; Peters C; Pagenstecher A; Bertalanffy H; Sure U
    Stroke; 2009 Mar; 40(3):820-6. PubMed ID: 19118244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential regulation of the pro-inflammatory biomarker, YKL-40/CHI3L1, by PTEN/Phosphoinositide 3-kinase and JAK2/STAT3 pathways in glioblastoma.
    Wang Y; Wong CW; Yan M; Li L; Liu T; Or PM; Tsui SK; Waye MM; Chan AM
    Cancer Lett; 2018 Aug; 429():54-65. PubMed ID: 29729901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pten signaling in gliomas.
    Knobbe CB; Merlo A; Reifenberger G
    Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiation-Induced DNA Damage Cooperates with Heterozygosity of TP53 and PTEN to Generate High-Grade Gliomas.
    Todorova PK; Fletcher-Sananikone E; Mukherjee B; Kollipara R; Vemireddy V; Xie XJ; Guida PM; Story MD; Hatanpaa K; Habib AA; Kittler R; Bachoo R; Hromas R; Floyd JR; Burma S
    Cancer Res; 2019 Jul; 79(14):3749-3761. PubMed ID: 31088835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.